您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。[港股财报]:三叶草生物-B2025中期报告 - 发现报告

三叶草生物-B2025中期报告

2025-09-18港股财报王***
AI智能总结
查看更多
三叶草生物-B2025中期报告

Clover Biopharmaceuticals, Ltd.三葉草生物製藥有限公司 (於開曼群島註冊成立的有限公司)股份代號:2197 目錄表 2公司資料4財務摘要6業務摘要7管理層討論與分析19其他資料42中期簡明綜合損益表43中期簡明綜合全面收益表44中期簡明綜合財務狀況表46中期簡明綜合權益變動表48中期簡明綜合現金流量表50中期簡明綜合財務資料附註77釋義 PO Box 309, Ugland HouseGrand Cayman, KY1-1104Cayman Islands Donna Marie AMBROSINORalf Leo CLEMENS20256 19 Jeffrey FARROWThomas LEGGETT 7581901 Thomas LEGGETTJeffrey FARROW 33191901 Maples Fund Services (Cayman) LimitedPO Box 1093, Boundary HallCricket SquareGrand CaymanKY1-1102Cayman Islands Donna Marie AMBROSINO20257 120257 1Thomas LEGGETT 183171712-1716 2197 www.cloverbiopharma.com 202111 5 15323203-3207 892323203A-5 202412 31556.5165.920256 30390.6 20256 303.3AdimFlu-S (QIS) 20246 3067.149.520256 3017.62024 20246 306.71.820256 304.9AdimFlu-S (QIS) 20246 3042.112.931%20256 3029.2 20246 3098.315.120256 3083.2 20256 303.8AdimFlu-S (QIS) 20246 3095.16.220256 30101.32024 F-(RSV-hMPV-PIV3) •20253RSVSCB-1019IND•20256(FiC)SCB-1022(RSV+hMPV)SCB-1033(RSV+hMPV+PIV3)•SCB-1022SCB-1033F (PreF)- AdimFlu-S (QIS) •20256AdimFlu-S (QIS) SCB-219M •SCB-219MTPOFc(CIT)•202411IbSCB-219MCIT •202212(EUA) SCB-2019CpG1018F-(RSV-hMPV-PIV3)Trimer-TagTrimer-TagTrimer-TagCICPICTrimer-Tag IRSVF(PreF)-SCB-1019SCB-1022 (RSV + hMPV)SCB-1033 (RSV +hMPV + PIV3)2025 3INDSCB-1019RSVGSKRSV(AREXVY)6085SCB1019AREXVY20256RSV + HMPVPIV3I1926085SCB-1022(RSV + hMPV)SCB-1033 (RSV + hMPV + PIV3)SCB-1019 (RSV)RSVF (PreF)- F-(RSV-hMPV-PIV3)RSV(BiC)(FiC) F-(RSV-hMPV-PIV3) 2025IRSVF(PreF)-SCB-1019SCB-1022 (RSV+hMPV)SCB-1033(RSV+hMPV+PIV3INDSCB-1019RSV20253GSKRSV(AREXVY)6085SCB-1019AREXVY20256RSV+HMPVPIV3I1926085SCB-1022 (RSV+hMPV)SCB-1033 (RSV+hMPV+PIV3)SCB-1019 (RSVRSVF (PreF)- AdimFlu-S (QIS) 20232AdimFlu-S (QIS) 20256AdimFlu-S (QIS) SCB-219M SCB-219MTPOFc(CIT)TPOSCB-219M(ADA) •202312SCB-219MI 202411IbSCB-219MCIT •202212(EUA) • 20256 30107 RSVSCB-1019SCB-1022SCB-1033GMP(DML) F-(RSV-hMPV-PIV3) (1)(2) Trimer-TagF-(RSV-hMPV-PIV3)2024SCB-1019I2025RSVRSV + hMPVPIV3RSVSCB-1019SCB-1022 SCB-1033(BiC)(FiC) 20256 303.3AdimFlu-S (QIS) 20246 3067.149.520256 3017.62024 20246 306.71.820256 304.9AdimFlu-S (QIS) (i)(ii)(iii)(iv) 20246 3042.112.931%20256 3029.2 (i)(ii)(iii)(iv)(v) 20246 3098.315.120256 3083.2 20256 303.8AdimFlu-S (QIS) (i)(ii) 20246 304.34.120256 300.2 20246 3095.16.22025630101.3 202412 31556.5165.920256 30390.6 20256 30459.8390.62.240.411.814.8 20256 301,763.51,587.8111.152.612.0 20256 30 20256 3020256 30 20256 30 100%20256 30 20256 3013.1202412 31 20256 30 20256 3024320256 3061.920256 30 20214 1520219 26 20256 30XV352 1.20256 302.3.20213 164.20256 305.20256 306.20256 301,297,062,429 20256 30 20256 30XV23336 (1)AUT-XXI Hong Kong Holdings LimitedAUT-XXIAUT-XXI Holdings LimitedAUT HoldingAUT HoldingHH IMV Holdings, L.P.HH IMVHH IMVHillhouse Fund IV, L.P.Hillhouse FundHillhouseInvestment Management, Ltd.Hillhouse InvestmentAUT HoldingHH IMVHillhouse FundHillhouse InvestmentAUT-XXI JNRY V Holdings LimitedJNRYHillhouse InvestmentHillhouse InvestmentJNRY (2)99%42%58% 20256 3030,660,00070% (3)IIIIIIIVIVIV (4)20256 301,297,062,429 20256 30336 18 13.51B(1) Ralf Leo CLEMENS20256 19 13.51B(1) 3.21C1Thomas LEGGETTJeffrey FARROWThomasLEGGETTJeffrey FARROW3.10(2)3.21 20256 30 13.2013.2113.22 20214 15 (a) (b) (i)(ii)(iii)(iv) (c) 25,947,096 (d) (e) (f) 20256 30 (1)(2)20256 301,297,062,429 1,710,8170.13% 20214 1520219 2620244 2 (a) (b) (i)(ii)(iii)(iv) (c) 77,350,0005.96%1,297,386,679 (d) (e) (a)(b) (5) (f) 10202141520219 266 (g) 20256 304221,679,42320256 30 (1)20256 301,297,062,429(2)25%36(1/48)(3)(4)25%25%(5)(25%)20236 15(6)(i)(1/48)25%75%(ii)(1/48)(7)(i)(25%)(ii)(25%)202312 1(8)(25%)20234 1(75%)(9)(10)20223 3120225 1220227 19202212 1520234 1120244220251 2020254 26.993.113.623.51.650.410.2290.22320223 3120225 1220227 19202212 1520234 1120244 220251 2020254 26.92.823.643.241.820.400.2220.2230.2320242.431 (11)202212 1620231 31(12)20235 302023(13)(14)(25%)20244 2(15)20244 2(16)(25%)20244 2(75%)(17)106,00020244 2(18)(25%)20251 20(19)(25%)20254 2(20)20254 2(21)(25%)20254 2(75%) 28,314,02814,639,694 20219 26 (a) (b) (i)(ii)(iii)(iv) (c) 1,158,114,72310%115,811,472115,547,886(i)(ii)8.91% (d) 121%12 (e) (f) (i)(ii)(iii) (g) (h) 20219 2610610 (i) 20256 3012933,531,66020256 30 (1)20223 3120225 1220227 19202212 1520234 1120244 220254 26.993.113.623.51.650.410.22320223 3120225 1220227 19202212 1520234 1120244 220254 24.151.242.231.600.990.220.1220242.431(2)10(3)20256 301,297,062,429(4)20225 520225(5)(6)(25%)20236 15(7)20234 1(8)(i)(1/48)25%75%(ii)(1/48)(9)(i)(25%)(ii)(25%)202312 1(10)(25%)20234 1(75%)(11) (12)20235 302023(13)20244 2(14)(25%)20244 2(75%)(15)20254 2(16)(25%)20254 2(75%) 85,945,72382,219,476 0.47% 202111 51,884.31,549.0 20238 2320238 2220238 22415.2 20256 301,544.599.7%20238 22 20256 30 1. 2. 202212 6202212 13202212 6128,000,000202212 13500.5449.0 20238 2320238 2220238 2269.4 20256 30439.898.0%2023822 20256 30 1. 2. 20256 30 • •••